Paul Feuerstadt MD FACG
Attending Physician Gastroenterology Center of Connecticut
Join to View Full Profile
2200 Whitney AveSuite 360Hamden, CT 06518
Phone+1 203-281-4463
Fax+1 203-287-2930
Dr. Feuerstadt is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Gastroenterology, 2007 - 2010
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2004 - 2007
Weill Cornell MedicineClass of 2004
Certifications & Licensure
CT State Medical License 2010 - 2027
NY State Medical License 2006 - 2027
FL State Medical License 2014 - 2016
American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012, 2014-2017
- CMS Meaningful Use Stage 1 Certification gGastro, gMed, Inc., 2012, 2014-2017
- CMS Meaningful Use Stage 2 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012, 2014-2017
Clinical Trials
- Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers Start of enrollment: 2014 Oct 01
Publications & Presentations
PubMed
- AGA Clinical Practice Update on Management of Clostridioides difficile Infection in Inflammatory Bowel Disease: Expert Review.Sahil Khanna, Jessica R Allegretti, Jana G Hashash, Paul Feuerstadt
Gastroenterology. 2026-05-15 - Diagnosis and Management of Clostridioides difficile.Colleen R Kelly, Paul Feuerstadt
The American Journal of Gastroenterology. 2026-03-01 - 1 citationsMulti-Species Synbiotic Supplementation After Antibiotics Promotes Recovery of Microbial Diversity and Function, and Increases Gut Barrier Integrity: A Randomized, Pla...Brooke A Napier, Jessica R Allegretti, Paul Feuerstadt, Colleen R Kelly, Nicholas W Van Hise
Antibiotics. 2026-01-30
Authored Content
- C. Difficile Infection at DDW 2023May 2023
Press Mentions
Ferring Presents New Phase 3b Safety and Effectiveness Data for Recurrent C. Diff Patients Receiving REBYOTA® (Fecal Microbiota, Live – Jslm) via Colonoscopy, and Additional Analyses at DDWMay 5th, 2025- Ferring Highlights Commitment to C. Diff Infection Community on the Second Anniversary of the Launch of REBYOTA® (Fecal Microbiota, Live – Jslm)January 27th, 2025
- ‘See C. Diff Diagnosed’ Campaign Aims to Spread Awareness, Defuse Public Health ThreatNovember 26th, 2024
Professional Memberships
- Fellow
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
